Literature DB >> 23205109

Roles of matrix metalloproteinase-26 in the growth, invasion and angiogenesis of breast cancer.

Hongfa Yang1, Yang Wang, Yilei Li, Lihong Zhang, Yiping Deng, Dongxue Qi, Yulin Li, Wei Li.   

Abstract

Matrix metalloproteinase-26 (MMP-26) is a novel member of the MMP family and plays a significant role in the progression of estrogen-dependent malignancies. The present study aimed to investigate the roles of MMP-26 in the growth, invasion and angiogenesis of breast cancer. pcDNA3.1(+)-neo expression plasmids carrying the proMMP-26 coding sequence were used to transfect a breast cancer cell line (MCF-7 cells). The mRNA and protein expression of MMP-26 was determined by RT-PCR, immunofluorescence analysis and flow cytometry. The morphology of transfected cells was observed under an electron microscope. An adherence and spreading assay, Boyden chamber assay, in vivo tumorigenicity assay and in vivo angiogenesis were further modeled to elucidate the roles of MMP-26 in the invasion and angiogenesis of breast cancer. Using electron microscopy, the MMP-26-transfected cells demonstrated increased atypia, including unusual mitotic figures, glucogen pools and special lysosomes in the cytoplasm. The adherence and spreading ability of MMP-26-transfected cells were increased significantly compared with cells in the control group. The Boyden chamber assay demonstrated that the migration and invasion ability of MMP-26-transfected cells was dramatically accelerated compared with the control group, but markedly reduced in the presence of anti-MMP-26 antibody. MMP-26 also increased the malignant phenotype in vivo. The number of vessel branches and the total length of vessels induced by MMP-26-transfected cells were significantly increased compared to those induced by non-transfected cells. The plasmid carrying the proMMP-26 gene was successfully transfected into breast cancer cells. Our results demonstrate that MMP-26 overexpression promotes the growth and invasion of breast cancer cells and induces angiogenesis.

Entities:  

Year:  2012        PMID: 23205109      PMCID: PMC3506671          DOI: 10.3892/ol.2012.833

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

Review 1.  ECM and cell surface proteolysis: regulating cellular ecology.

Authors:  Z Werb
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

2.  Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.

Authors:  H I Park; J Ni; F E Gerkema; D Liu; V E Belozerov; Q X Sang
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

3.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

Authors:  S Heymans; A Luttun; D Nuyens; G Theilmeier; E Creemers; L Moons; G D Dyspersin; J P Cleutjens; M Shipley; A Angellilo; M Levi; O Nübe; A Baker; E Keshet; F Lupu; J M Herbert; J F Smits; S D Shapiro; M Baes; M Borgers; D Collen; M J Daemen; P Carmeliet
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

Review 4.  Proteolysis-driven oncogenesis.

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  Cell Cycle       Date:  2007-01-12       Impact factor: 4.534

5.  Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

Authors:  G Giannelli; J Falk-Marzillier; O Schiraldi; W G Stetler-Stevenson; V Quaranta
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

6.  Non-small cell lung cancer invasion and metastasis promoted by MMP-26.

Authors:  Yang Zhang; Hang Zhao; Yeling Wang; Yong Lin; Yan Tan; Xuexun Fang; Lianwen Zheng
Journal:  Mol Med Rep       Date:  2011-07-26       Impact factor: 2.952

7.  Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin.

Authors:  Wei Li; Alexei Y Savinov; Dmitri V Rozanov; Vladislav S Golubkov; Hirad Hedayat; Tatiana I Postnova; Natalia V Golubkova; Yu Linli; Stanislaw Krajewski; Alex Y Strongin
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

8.  Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.

Authors:  R L Barnhill; M W Piepkorn; A J Cochran; E Flynn; T Karaoli; J Folkman
Journal:  Arch Dermatol       Date:  1998-08

9.  Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells.

Authors:  Vladislav S Golubkov; Alexey V Chekanov; Alexey Y Savinov; Dmitri V Rozanov; Natalya V Golubkova; Alex Y Strongin
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

10.  c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis.

Authors:  Lucia Knopfová; Petr Beneš; Lucie Pekarčíková; Markéta Hermanová; Michal Masařík; Zuzana Pernicová; Karel Souček; Jan Smarda
Journal:  Mol Cancer       Date:  2012-03-23       Impact factor: 27.401

View more
  2 in total

1.  Identification of the endoplasmic reticulum localization sequence and N-glycosylation of matrix metalloproteinase 26.

Authors:  Guangji Zhang; Jinrui Zhang; Xiang Li; Xin Meng; Xuexun Fang
Journal:  RSC Adv       Date:  2019-07-25       Impact factor: 4.036

2.  High MMP-26 expression in glioma is correlated with poor clinical outcome of patients.

Authors:  Jian-Gui Guo; Cheng-Cheng Guo; Zhen-Qiang He; Xiu-Yu Cai; Yong-Gao Mou
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.